Abnova

Rather than the traditional method of antibody production, Abnova is taking a genomic/proteomic approach for antibody development.

We manufacture all our products, recombinant proteins, and antibodies in our state-of-the-art production and SPF animal facilities. We also have multiple clones for the monoclonal antibody, and their access is available to partners and collaborators from academic institutions and industry.